NKGen Biotech: Funding, Investors & Team (Sep 2026)
NKGen Biotech, Inc. is a biotechnology company in the clinical stage that specializes in creating and selling advanced therapies using autologous, allogeneic, and CAR-NK Natural Killer (NK) cells. With unique technologies for expanding and activating cells, as well as advanced manufacturing capabilities, NKGen Biotech can multiply natural killer cells indefinitely and increase their ability to destroy harmful cells.
NKGen Biotech has raised $9.7M across 3 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Jul 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NKGen Biotech Company Profile and Key Stats
Latest funding round on record: Jul 2025.
NKGen Biotech Funding Rounds
NKGen Biotech raised $5.0M in an undisclosed round announced in Apr 2024.
1.1 years later, an undisclosed round of $2.7M was announced in May 2025.
2 months later, an undisclosed round of $2.0M was announced in Jul 2025.
NKGen Biotech Founders and Leadership Team
No contact details are on record for this team yet.
NKGen Biotech Funding Compared to Other Biotechnology Startups
NKGen Biotech's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NKGen Biotech in Biotechnology and Santa Ana
Companies Similar to NKGen Biotech
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
NKGen Biotech Funding FAQs
What does NKGen Biotech do?
NKGen Biotech, Inc. is a biotechnology company in the clinical stage that specializes in creating and selling advanced therapies using autologous, allogeneic, and CAR-NK Natural Killer (NK) cells. With unique technologies for expanding and activating cells, as well as advanced manufacturing capabilities, NKGen Biotech can multiply natural killer cells indefinitely and increase their ability to destroy harmful cells.
How much funding has NKGen Biotech raised?
NKGen Biotech has raised $9.7M across 3 rounds on record. The most recent is an undisclosed round of $2.0M announced in Jul 2025.
When did NKGen Biotech last raise funding?
NKGen Biotech's most recent funding round on record is an undisclosed round of $2.0M, announced in Jul 2025.
Who founded NKGen Biotech?
FundedIQ lists Sangwoo Park (Founder) at NKGen Biotech.
Where is NKGen Biotech headquartered?
NKGen Biotech is based in Santa Ana, California, United States.
How many employees does NKGen Biotech have?
NKGen Biotech is in the 51-100 employee band.
How does NKGen Biotech's funding compare to other Biotechnology startups?
NKGen Biotech's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's NKGen Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NKGen Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.